Vericel Corporation

VCEL ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $100.1M $74.5M $69.1M $51.1M $68.3M $33.6M $26.9M $18.3M
Accounts Receivable $84.6M $61.4M $58.4M $46.5M $37.4M $34.5M $32.2M $23.5M
Inventory $17.6M $17.4M $13.1M $16.0M $13.4M $9.4M $6.8M $3.6M
Total Current Assets $247.4M $212.8M $205.6M $186.9M $158.5M $123.6M $111.7M $112.8M
Property, Plant & Equipment — — — — — — — $5.9M
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) $5.6M $6.3M $6.9M $7.5M $0 — — —
Total Assets $488.0M $432.7M $353.7M $273.0M $243.7M $205.6M $153.2M $118.7M
Liabilities
Accounts Payable $15.8M $23.8M $22.3M $16.9M $9.0M $6.8M $6.3M $7.1M
Total Current Liabilities $49.1M $50.3M $45.7M $37.5M $26.1M $22.5M $19.8M $14.8M
Long-Term Debt — — — — — — — —
Total Liabilities $133.3M $140.8M $127.7M $80.7M $73.2M $71.3M $42.1M $16.5M
Stockholders' Equity
Retained Earnings $-376.3M $-392.8M $-403.2M $-400.0M $-383.3M $-375.8M $-378.7M $-369.0M
Total Stockholders' Equity $354.6M $292.0M $226.0M $192.3M $170.5M $134.3M $111.1M $102.2M
← Newer Page 1 of 2 Older →